[Federal Register Volume 62, Number 231 (Tuesday, December 2, 1997)]
[Notices]
[Pages 63721-63722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31586]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N-0260]


Agency Information Collection Activities; Submission for OMB 
Review; Comment Request

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
proposed collection of information listed below has been submitted to 
the Office of Management and Budget (OMB) for review and clearance 
under the Paperwork Reduction Act of 1995 (the PRA).

DATES: Submit written comments on the information collection by January 
2, 1998.

ADDRESSES: Submit written comments on the collection of information to 
the Office of Information and Regulatory Affairs, OMB, New Executive 
Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: 
Desk Officer for FDA.

FOR FURTHER INFORMATION CONTACT: Mark L. Pincus, Office of Information 
Resources Management (HFA-80), Food and Drug Administration, 5600 
Fishers Lane, rm. 16B-31, Rockville, MD 20857, 301-827-1471.

SUPPLEMENTARY INFORMATION: In compliance with section 3507 of the PRA 
(44 U.S.C. 3507), FDA has submitted the following proposed collection 
of information to OMB for review and clearance:

Customer/Partner Satisfaction Surveys

    Under section 903 of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 393), FDA is authorized to conduct research relating to 
regulated articles and to conduct educational and public information 
programs relating to the responsibilities of the agency. Executive 
Order 12862, entitled ``Setting Customer Service Standards,'' directs 
Federal agencies that ``provide significant services directly to the 
public'' to ``survey customers to determine the kind and quality of 
services they want and their level of satisfaction with existing 
services.'' FDA is seeking OMB

[[Page 63722]]

clearance to conduct a series of surveys to implement Executive Order 
12862. Participation in the surveys will be voluntary. This request 
covers customer service surveys of regulated entities, such as food 
processors; cosmetic, drug, biologic and medical device manufacturers; 
consumers; and health professionals. The request also covers partner 
surveys of State and local governments.
    FDA will use the information gathered through these surveys to 
identify strengths and weaknesses in service provided to customers and 
partners and to make improvements in it. The surveys will assess 
timeliness, appropriateness, accuracy of information, courtesy, and 
problem resolution in the context of individual programs.
    In the Federal Register of July 15, 1997 (62 FR 37923), FDA invited 
comments on this proposed collection of information. FDA received no 
comments in response to this notice.
    FDA estimates the burden of this collection of information as 
follows:

              Table 1.--Estimated Annual Reporting Burden1              
------------------------------------------------------------------------
                              Annual                                    
 Type of      No. of       Frequency per     Hours per      Total Hours 
 Survey     Respondents      Response        Response                   
------------------------------------------------------------------------
Mail/                                                                   
 telepho                                                                
 ne                                                                     
 surveys   29,040               1               0.09        2,614       
Total      29,040               1               0.09        2,614       
------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs       
  associated with this collection of information.                       

    These estimates are based on experience with other surveys FDA has 
conducted, and they have been adjusted downward since the July 15, 
1997, notice because the agency plans to conduct fewer surveys than 
previously anticipated. In addition, the agency does not believe that 
focus groups will be necessary for effective implementation of 
Executive Order 12862.

    Dated: November 23, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-31586 Filed 12-1-97; 8:45 am]
BILLING CODE 4160-01-F